Activators of the nuclear receptor PPARγ enhance colon polyp formation

Nature Medicine

Volumn 4, Issue 9, 1998, Pages 1058-1061

  Saez, Enrique ^a   Tontonoz, Peter ^a,b   Nelson, Michael C ^a   Alvarez, Jacqueline G A ^a   Ming U, Tze ^a   Baird, Stephen M ^b,c   Thomazy, Vilmos A ^d   Evans, Ronald M ^a  

^a HOWARD HUGHES MEDICAL INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CELL NUCLEUS RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; SULINDAC; TROGLITAZONE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER RISK; CARCINOGENESIS; COLON POLYP; COLON TUMOR; CONTROLLED STUDY; DRUG EFFECT; FAT INTAKE; GENE EXPRESSION; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR INTRINSIC ACTIVITY;

ADENOCARCINOMA; ADENOMATOUS POLYPOSIS COLI; ANIMALS; CHROMANS; DIET; HUMANS; LIGANDS; MICE; MICE, INBRED C57BL; RECEPTORS, CYTOPLASMIC AND NUCLEAR; THIAZOLES; THIAZOLIDINEDIONES; TRANSCRIPTION FACTORS;

ANIMALIA;

EID: 0031667938     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/2042     Document Type: Article

References (35)

1. The World Health Organization in The World Health Report (World Health Organization, Geneva, 1997).
2. Weisburger, J. H. Dietary fat and risk of chronic disease: mechanistic insights from experimental studies. J. Am. Diet. Assoc. 97 (suppl.) S16-S23 (1997).
3. Giovannucci, E. & Goldin, B. The role of fat, fatty acids, and total energy intake in the etiology of human colon cancer. Am. J. Clin. Nutr. 66 (suppl.) 1564S-1571S (1997).
4. Reddy, B. S., Tanaka, T. & Simi, B. Effect of different levels of dietary trans fat or corn oil on azoxymethane-induced colon carcinogenesis in F344 rats. J. Natl. Cancer Inst. 75, 791-798 (1985).
5. Reddy, B. S., Burill, C. & Rigotty, J. Effects of diets high in ω-3 and ω-6 fatty acids on initiation and postinitiation stages of colon carcinogenesis. Cancer Res. 51, 487-491 (1991).
6. Δ716 knockout mice. Carcinogenesis 18, 1863-1865 (1997).
7. Reddy, B. S. & Sugie, S. Effect of different levels of omega-3 and omega-6 fatty acids on azoxymethane-induced colon carcinogenesis in F344 rats. Cancer Res. 48, 6642-6647 (1988).
8. Klurfled, D. M. & Bull, A. W. Fatty acids and colon cancer in experimental models. Am. J Clin. Nutr. 66 (suppl.) 1530S-1538S (1997).
9. Mangelsdorf, D. J. et al. The nuclear receptor superfamily: the second decade. Cell 83, 835-841 (1995).
10. Kliewer, S. A. et al. Differential expression and activation of a family of murine peroxisome proliferator-activated receptors. Proc. Natl. Acad. Sci. USA 91, 7355-7359 (1994).
11. Dreyer, C. et al. Control of the peroxisomal β-oxidation pathway by a novel family of nuclear hormone receptors. Cell 68, 879-887 (1992).
12. Tontonoz, P., Hu, E. & Spiegelman, B. M. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor. Cell 79, 1147-1156 (1994).
13. Forman, B. M. et al. M. 15-deoxy-Δ12,1 - prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ. Cell 83, 803-812 (1995).
14. 2 metabolite binds peroxisome proliferator-activated receptor γ and promotes adipocyte differentiation. Cell 83, 813-819 (1995).
15. Forman, B. M., Chen, J. & Evans, R. M. Hypolipidemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ. Proc. Natl. Acad. Sci. USA 94, 4312-4317 (1997).
16. Kliewer, S. A. et al. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors α and γ. Proc. Natl. Acad. Sci. USA 94, 4318-4323 (1997).
17. Kargman, S. L. et al. Expression of prostaglandin G/H synthetase-1 and -2 protein in human colon cancer. Cancer Res. 55, 2556-2559 (1995).
18. Sano, H. et al. Expression of cyclooxygenase-1 and -2 in human colorectal cancer. Cancer Res. 55, 3785-3789 (1995).
19. Δ716 knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell 87, 803-809 (1996).
20. Sinqh, J., Hamid, R. & Reddy, B. S. Dietary fat and colon cancer: modulation of cyclooxygenase-2 by types and amount of dietary fat during the postinitiation stage of colon carcinogenesis. Cancer Res. 57, 3465-3470 (1997).
21. Min: a mouse model for intestinal and mammary tumorigenesis. Eur. J. Cancer 31A, 1061-1064 (1995).
22. Cantello, B. C. C. et al. [[ω-(Heterocyclyamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents. J. Med. Chem. 37, 3977-3985 (1994).
23. Lehmann, J. M. et al. An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ (PPARγ). J. Biol. Chem. 270, 12953-12956 (1995).
24. Min/+ mice. Nature Med. 4, XXX-XXX (1998).
25. DuBois, R. N. et al. The nuclear eicosanoid receptor, PPARγ, is aberrantly expressed in colonic cancers. Carcinogenesis, 19, 49-53 (1998).
26. Reddy, B. S. & Maeura, Y. Tumor promotion by dietary fat in azoxymethane-induced colon carcinogenesis in female F344 rats: influence of amount and source of dietary fat. J Natl. Cancer Inst. 72, 745-750 (1984).
27. Temple, N. J. & El-Khatib, S. M. Effect of high fat and nutrient depleted diets on colon tumor formation in mice. Cancer Lett. 37, 109-114 (1987).
28. Hogan, M. L. & Shamsuddin, A. M. Large intestinal carcinogenesis. I. Promotional effect of dietary fatty acid isomers in the rat model. J. Natl. Cancer Inst. 73, 1293-1296 (1984).
29. Wasan, H. S., Novelli, M., Bee, J. & Bodmer, W. F. Dietary fat influences on polyp phenotype in multiple intestinal neoplasia mice. Proc. Natl. Acad. Sci. USA 94, 3308-3313 (1997).
30. Δ716 knockout mice. Carcinogenesis, 16, 2605-2607 (1995).
31. Tontonoz, P., Nagy, L., Alvarez, J. G. A., Thomazy, V. A. & Evans, R. M. PPARγ promotes monocyte/macrophage differentiation and uptake of oxidized LDL. Cell, 93, 241-252 (1998).
32. Tontonoz, P. et al. Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor. Proc. Natl. Acad. Sci. USA 94, 237-241 (1997).
33. Mueller, E. et al. Terminal differentiation of human breast cancer through PPARγ. Molecular Cell 1, 465-470 (1998).
34. Berger, J. et al. Thiazolidinediones produce a conformational change in peroxisomal proliferator-activated receptor-γ: binding and activation correlate with antidiabetic actions in db/db mice. Endocrinology 137, 4189-4501 (1996).
35. Kinzler, K. W. & Vogelstein, B. Lessons from hereditary colorectal cancer. Cell 87, 159-170 (1996).